# Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

> **NCT06989099** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Lymphedema

## Interventions

- **PROCEDURE:** Immediate Lymphatic Reconstruction (ILR)/
- **PROCEDURE:** Prophylactic Lymphovenous Bypass (pLVB)

## Key facts

- **NCT ID:** NCT06989099
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-24
- **Primary completion:** 2028-08-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06989099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06989099, "Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06989099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*